Exploring the role of VEGF in Indian age related macular degeneration

Annals of Neurosciences

Volumn 22, Issue 4, 2015, Pages 232-237

  Sharma, Kaushal ^a,b   Sharma, Neel K ^c   Singh, Ramandeep ^a   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

^c NATIONAL EYE INSTITUTE   (United States)

Author keywords

Age related; Anti VEGF; Heart ailment; Macular degeneration; VEGF

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOCIAL STATUS;

EID: 84928798046     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.220408     Document Type: Article

References (40)

1. Liegl R, Koenig S, Siedlecki J, et al. Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression. PLoS One. 2014; 9(2): e88203.
2. Zehetner C, Kirchmair R, Neururer SB, et al. Systemic upregulation of PDGF-B in patients with neovascular AMD. Invest Ophthalmol Vis Sci. 2014; 55(1): 337-44.
3. Zeng J, Jiang D, Liu X et al. Matrix metalloproteinases expression in choroidal neovascular membranes. Yan Ke Xue Bao. 2004; 20(3): 191-3.
4. Anand A, Sharma K, Chen W, Sharma NK. Using current data to define new approach in age related macular degeneration: need to accelerate translational research. Curr Genomics. 2014 Aug; 15(4): 266-77.
5. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Experimental Eye Research. 2006; 82(1): 99-110.
6. Vidro-Kotchan E, Yendluri BB, Le-Thai T, et al. NBHA reduces acroleininduced changes in ARPE-19 cells: possible involvement of TGFβ. Curr Eye Res. 2011; 36(4): 370-8.
7. Zhang L, Lim SL, Du H, et al. High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-β family member growth differentiation factor 6. J Biol Chem. 2012; 287(2): 1520-6.
8. Nagineni CN, Samuel W, Nagineni S, et al. Transforming growth factorbeta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogenactivated protein kinases. J Cell Physiol. 2003; 197(3): 453-62.
9. Sharma K, Anand A, Sharma NK. Why AMD is a disease of ageing and not of development: mechanisms and insights. Front Aging Neurosci. 2014; 6: 151.
10. Nozaki M, Raisler BJ, Sakurai E, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A. 2006; 103(7): 2328-33.
11. Jonas JB, Neumaier M. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema. Ophthalmic Res. 2007; 39(3): 139-42.
12. Lee SJ, Kim JH, Kim JH, et al. Human apolipoprotein E2 transgenic mice show lipid accumulation in retinal pigment epithelium and altered expression of VEGF and bFGF in the eyes. J Microbiol Biotechnol. 2007; 17(6): 1024-30.
13. Haines JL, Schnetz-Boutaud N, Schmidt S, et al. Functional candidate genes in age-related macular degeneration: signif- icant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci. 2006; 47: 329-335.
14. Sharma NK, Sudesh Prabhakar S, Anand A. Age related macular degeneration - advances and trends. Annals of Neurosciences.2009; 2: 62-71.
15. Grisanti S, Zhu Q, Tatar O, et al. Differential expression of vascular endothelial growth factor-A isoforms in neovascular age related macular degeneration. Retina. 2014. [Epub ahead of print].
16. Suganthalakshmi B, Anand R, Kim R, et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis. 2006; 12: 336-341.
17. Watson CJ, Webb NJA, Bottomley MJ et al. Identification of polymorphisms within the vascular endothelial growth factor [VEGF] gene: correlation with variation in VEGF protein production. Cytokine. 2000; 12: 1232-1235.
18. Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet. 2006; 15: 2955-2961.
19. Grisanti S, Zhu Q, Tatar O, et al. Differential expression of vascular endothelial growth factor-A isoforms in neovascular age related macular degeneration. Retina. 2014. [Epub ahead of print].
20. Ablonczy Z, Dahrouj M, Marneros AG. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels. FASEB J. 2014; 28(5): 2369-79.
21. Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005; 167(5): 1451-9.
22. Sharma NK, Gupta A, Prabhakar S, et al. Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration. Curr Neurovasc Res. 2012; 9(4): 256-65.
23. Sharma NK, Gupta A, Prabhakar S, et al. Serum levels and polymorphism investigation in CFH loci in age related macular degeneration. PLoS ONE 8(7): e70193.
24. Anand A, Sharma NK, Gupta A, et al. Superoxide Dismutase1 Levels in North Indian Population with Age-Related Macular Degeneration.
25. Anand A, Sharma NK, Singh R, et al. Does DcR1 (TNF-related apoptosisinducing- ligand Receptor 3) have any role in human AMD pathogenesis? Sci Rep. 2014; 4: 4114.
26. Sharma NK, Sharma K, Gupta A, et al. Does Toll like receptor-3 have any role in Indian AMD phenotype? Molecular and Cellular Biochemistry. 2014; 393(1-2): 1-8.
27. Sharma NK, Sharma SK, Gupta A, et al. Predictive model for earlier diagnosis of suspected AMD patients. DNA and Cell Biology, 2013; 32(9): 549-555.
28. Reich SJ, Fosnot J, Kuroki A, et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis. 2003; 9: 210-6.
29. Cashman SM, Bowman L, Christofferson J, et al. Inhibition of Choroidal Neovascularization by Adenovirus-Mediated Delivery of Short Hairpin RNAs Targeting VEGF as a Potential Therapy for AMD. Invest. Ophthalmol. Vis. Sci. 2006; 47 (8): 83496-3504.
30. Nagineni CN, Kommineni VK, William A, et al. Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. J Cell Physiol. 2012; 227(1): 116-26.
31. Anand A, Sharma NK, Gupta A, et al. Single nucleotide polymorphisms in MCP-1 and its receptor are associated with the risk of age related macular degeneration. PLoS One. 2012; 7(11): e49905.
32. Sharma NK, Gupta A, Prabhakar S, et al. CC chemokine receptor-3 as new target for age-related macular degeneration. Gene. 2013; 523(1): 106-11.
33. Sharma NK, Prabhakar S, Gupta A, et al. New biomarker for neovascular age-related macular degeneration: eotaxin-2. DNA Cell Biol. 2012; 31(11): 1618-27.
34. Snow KK, Seddon JM. Do age related macular degeneration and cardiocascular disease share common antecedents? Ophthalmic Epidemiol. 1999; 6(2): 125-43.
35. Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000; 118(3): 351-8.
36. Felmeden DC, Spencer CG, Belgore FM, et al. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens. 2003; 16(1): 11-20.
37. Lip PL, Blann AD, Hope-Ross M, et al. Age related macular degeneration is associated with increased vascular endothelial growth factors, hemorheology and endothelial dysfunction. Ophthalmology. 2001; 108(4): 705-10.
38. Zehetner C, Kirchmair R, Huber S, et al. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema. Br J Ophthalmol. 2013; 97(4): 454-9.
39. Carneiro AM, Costa R, Falcão MS, et al. Vascular endothelial growth factor plasma levels before and after treatment of neovascular agerelated macular degeneration with bevacizumab or ranibizumab. Acta Ophthalmol. 2012; 90(1): e25-30.
40. Ohno-Matsui K, Morita I, Tombran-Tink J et al. Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physio.2001; 189(3): 323-333.